Quarterly report pursuant to Section 13 or 15(d)

NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.24.3
NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

    For the three and nine months ended September 30,  
    2024     2023  
             
Shares of common stock issuable upon exercise of stock options     177,138       223,323  
Shares of common stock underlying restricted stock     3,268,414       2,308,924  
Shares of common stock issuable upon exercise of conversion feature of loan agreement     614,251        
Shares of common stock issuable upon exercise of warrants     9,987,560       9,397,879  
Total     14,047,363       11,930,126